Literature DB >> 22377817

Peripheral nerve inflammation in ALS mice: cause or consequence.

Osamu Kano1, David R Beers, Jenny S Henkel, Stanley H Appel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22377817      PMCID： PMC3304948          DOI： 10.1212/WNL.0b013e318249f776

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Authors:  Stanley H Appel; David R Beers; Jenny S Henkel
Journal:  Trends Immunol       Date:  2009-10-31       Impact factor: 16.687

2.  From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.

Authors:  John M Lincecum; Fernando G Vieira; Monica Z Wang; Kenneth Thompson; Gerald S De Zutter; Joshua Kidd; Andrew Moreno; Ricardo Sanchez; Isarelis J Carrion; Beth A Levine; Bashar M Al-Nakhala; Shawn M Sullivan; Alan Gill; Steven Perrin
Journal:  Nat Genet       Date:  2010-03-28       Impact factor: 38.330

3.  Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

Authors:  Isaac M Chiu; Hemali Phatnani; Michael Kuligowski; Juan C Tapia; Monica A Carrasco; Ming Zhang; Tom Maniatis; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

4.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

5.  A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice.

Authors:  Smita Saxena; Erik Cabuy; Pico Caroni
Journal:  Nat Neurosci       Date:  2009-03-29       Impact factor: 24.884

6.  Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF.

Authors:  George K Tofaris; Paul H Patterson; Kristjan R Jessen; Rhona Mirsky
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

7.  Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.

Authors:  David R Beers; Jenny S Henkel; Weihua Zhao; Jinghong Wang; Ailing Huang; Shixiang Wen; Bing Liao; Stanley H Appel
Journal:  Brain       Date:  2011-05       Impact factor: 13.501
  7 in total
  23 in total

Review 1.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 2.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.

Authors:  Emiliano Trias; Mariángeles Kovacs; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Ivan C Moura; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  Glia       Date:  2019-12-20       Impact factor: 7.452

4.  Non-steroidal anti-inflammatory drugs and amyotrophic lateral sclerosis: results from five prospective cohort studies.

Authors:  Elinor Fondell; Éilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Marjorie L McCullough; Michael J Thun; Yikyung Park; Laurence N Kolonel; Alberto Ascherio
Journal:  Amyotroph Lateral Scler       Date:  2012-08-07

Review 5.  CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.

Authors:  Kathryn J Jones; Amy E Lovett-Racke; Chandler L Walker; Virginia M Sanders
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-07       Impact factor: 4.147

6.  Delayed functional recovery in presymptomatic mSOD1G93A mice following facial nerve crush axotomy.

Authors:  Nichole A Mesnard; Melissa M Haulcomb; Lisa Tanzer; Virginia M Sanders; Kathryn J Jones
Journal:  J Neurodegener Regen       Date:  2013

7.  A pilot trial of RNS60 in amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Mohamad J Alshikho; Sarah Luppino; James Chan; Lindsay Pothier; David Schoenfeld; Patricia L Andres; Suma Babu; Nicole R Zürcher; Marco L Loggia; Robert L Barry; Silvia Luotti; Giovanni Nardo; Maria Chiara Trolese; Serena Pantalone; Caterina Bendotti; Valentina Bonetto; Fabiola De Marchi; Bruce Rosen; Jacob Hooker; Merit Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2018-12-26       Impact factor: 3.217

8.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04

9.  Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.

Authors:  Franck Patin; Thomas Baranek; Patrick Vourc'h; Lydie Nadal-Desbarats; Jean-François Goossens; Sylviane Marouillat; Anne-Frédérique Dessein; Amandine Descat; Blandine Madji Hounoum; Clément Bruno; Hervé Watier; Mustafa Si-Tahar; Samuel Leman; Jean-Claude Lecron; Christian R Andres; Philippe Corcia; Hélène Blasco
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 10.  Mast cells, glia and neuroinflammation: partners in crime?

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.